Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory - to help you find the best companies. Keeping that in mind, here are three value stocks with poor fundamentals and some alternatives you should consider instead.
Malibu Boats (MBUU)
Forward P/E Ratio: 12x
Founded in California in 1982, Malibu Boats (NASDAQ: MBUU) is a manufacturer of high-performance sports boats and luxury watercrafts.
Why Should You Dump MBUU?
- Muted 1.5% annual revenue growth over the last five years shows its demand lagged behind its consumer discretionary peers
- Free cash flow margin is anticipated to expand by 1.5 percentage points over the next year, providing additional flexibility for investments and share buybacks/dividends
- Eroding returns on capital from an already low base indicate that management’s recent investments are destroying value
Malibu Boats is trading at $24.86 per share, or 12x forward P/E. Read our free research report to see why you should think twice about including MBUU in your portfolio.
Option Care Health (OPCH)
Forward P/E Ratio: 9.9x
With a nationwide network of 177 locations serving 43 states and a team of over 4,500 clinicians, Option Care Health (NASDAQ: OPCH) is the largest independent provider of home and alternate site infusion services, delivering medications and clinical support to patients across the United States.
Why Does OPCH Fall Short?
- Estimated sales growth of 2.5% for the next 12 months implies demand will slow from its two-year trend
- Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 1.7 percentage points
Option Care Health’s stock price of $20.95 implies a valuation ratio of 9.9x forward P/E. Check out our free in-depth research report to learn more about why OPCH doesn’t pass our bar.
First Merchants (FRME)
Forward P/B Ratio: 0.9x
Dating back to 1893 when it first opened its doors in Indiana, First Merchants (NASDAQ: FRME) is a Midwest regional bank providing commercial, consumer, and wealth management services through branches in Indiana, Ohio, Michigan, and Illinois.
Why Are We Wary of FRME?
- Annual revenue growth of 3.7% over the last two years was below our standards for the banking sector
- Annual net interest income growth of 7.5% over the last five years was below our standards for the banking sector
- Earnings growth underperformed the sector average over the last two years as its EPS grew by just 4% annually
At $39.60 per share, First Merchants trades at 0.9x forward P/B. If you’re considering FRME for your portfolio, see our FREE research report to learn more.
Stocks We Like More
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week - FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
